Quantitative Multimodal Fluorescence and Bioluminescence Tomography with the MILabs OI-CT System

by Dr. Felix Gremse, RWTH Aachen University and Gremse IT

Hybrid fluorescence tomography and x-ray computed tomography (FLT-CT) provided by the MILabs OI-CT system allows non-invasive longitudinal volumetric assessment of fluorescent probes in mice in vivo. This talk demonstrates that FLT-CT can be used to quantitatively determine the biodistribution NIRF-labeled probes. It also demonstrates the functionality for multimodal bioluminescence tomography (BLT-CT) which uses multispectral images to identify deep luminescent sources such as luciferase-expressing tumors and metastases.

Took place: August, 2020 (at vEMIM)

Back to all webinars

You may also like

Multimodal in vivo imaging of CAR T cell therapies using MILab’s OI-CT system
This webinar describes Miltenyi Biotech’s approach establishing multimodal optical imaging of CAR T cell therapies, using the MILabs optical imaging micro CT system.
Multiscale optical imaging for unraveling the in vivo fate of nanomedicine
The Institute for Experimental Molecular Imaging’s (RWTH Aachen) research team uses MILabs Optical imaging system, intravital microscopy, and immunohistochemistry to investigate cancer nanomedicine delivery and uptake in vivo.
Dual Isotope Imaging Using the MILabs VECTorCT: Applications in Oncology
This webinar covers some recent groundbreaking studies conducted by the Cornelissen group in Oxford. Several recent papers will be presented including ‘Early detection in a mouse model of pancreatic cancer by imaging DNA damage response signaling’, ‘Dual-isotope antibody imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours’, and ‘Imaging DNA Damage Repair in vivo Following 177Lu-DOTATATE Therapy’.
Scroll to Top